S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer
Phase NA Completed
658 enrolled 19 charts
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Phase 2 Completed
37 enrolled 19 charts
COXEN
Phase 2 Completed
237 enrolled 20 charts
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
Phase 1 Completed
40 enrolled
Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract
Phase 2 Completed
40 enrolled
Chemotherapy in Treating Patients With Early-Stage Bladder Cancer
Phase 2 Completed
75 enrolled
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
Phase 3 Completed
330 enrolled
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
Phase 2 Completed
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
Phase 2 Completed
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
Combination Chemotherapy in Treating Patients With Bladder Cancer
Phase 3 Completed
490 enrolled
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
Phase 2 Completed
70 enrolled 18 charts
S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Phase 3 Completed
406 enrolled 16 charts
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer
Phase 2 Completed
97 enrolled 8 charts
Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
Phase 3 Completed
285 enrolled
S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
Phase 2 Completed
58 enrolled 8 charts
Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer
Phase 1 Completed
18 enrolled
Surgery and BCG in Treating Patients With Bladder Cancer
Phase 3 Completed
1,288 enrolled
Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium
Phase 2/3 Completed
238 enrolled
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
Phase 3 Completed
608 enrolled
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
Phase 2 Completed
77 enrolled 11 charts
S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
Phase 2 Completed
7 enrolled
S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
Phase 2 Completed
45 enrolled
S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
Phase 2 Completed
31 enrolled
Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract
Phase 2 Completed
21 enrolled
SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract
Phase 2 Completed
34 enrolled
BCG With or Without Mitomycin in Treating Patients With Bladder Cancer
Phase 2 Completed
97 enrolled